Pharmacology of a new antitussive agent: meprotixol (N 7020).
D000109:Acetylcholine / Q000494:pharmacology; D000758:Anesthesia / Q000187:drug effects; D000818:Animals; D000996:Antitussive Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D003061:Codeine / Q000494:pharmacology; D004336:Drug Antagonism; D004357:Drug Synergism; D004562:Electrocardiography; D004594:Electrophysiology; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D051379:Mice; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology* / Q000633:toxicity*
D000996:Antitussive Agents; D014970:Xanthines; D012701:Serotonin; D000109:Acetylcholine; D003061:Codeine; D009638:Norepinephrine; D004837:Epinephrine